Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present American Cryostem Corp. (OTC: CRYO).

Full DD Report for CRYO

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-130.590.46510.600.4046,072
2018-12-120.380.440.45990.381,595
2018-12-110.400.43940.45990.38517,500
2018-12-100.40050.58680.58680.40054,610
2018-12-070.480.4750.480.40054,945

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1330,50546,07266.2116Short
2018-12-121001,5956.2696Cover
2018-12-119,50017,50054.2857Short
2018-12-102004,6104.3384Cover
2018-12-062001,31815.1745Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CRYO.


About American Cryostem Corp. (OTC: CRYO)

Logo for American Cryostem Corp. (OTC: CRYO)

A pioneer in the fields of Regenerative and Personalized Medicine, American CryoStem is a developer, marketer and global licensor of patented adipose tissue based cellular technologies and related proprietary services with a focus on clinical processing, commercial bio banking and application development for adipose fat tissue and autologous adipose derived regenerative cells ADRCs . The Company maintains a strategic portfolio of intellectual property and patent applications that form its Adipose Tissue Processing Platform, which supports and promotes a growing pipeline of biologic products and processes, clinical services and international licensing opportunities. Through its ACS Laboratories division, the Company operates an FDA registered, cGMP compliant human tissue processing, cryo storage, cell culture and differentiation media development facility in Mount Laurel, New Jersey.

 

 

 

Current Management

  • John Arnone / CEO
  • Anthony Dudzinski / COO, Secretary, Treasurer
  • Ruth Goldman / Vice President, Other
  • John DiFolco / Director, Mkt.
  • John Arnone / Chairman
  • Anthony Dudzinski /

Current Share Structure

  • Market Cap: $25,490,649 - 03/20/2018
  • Authorized: 300,000,000 - 09/30/2013
  • Issue and Outstanding: 45,519,016 - 02/12/2018
  • Float: 7,820,000 - 09/30/2016

 


Recent Filings from (OTC: CRYO)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: January, 16 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: December, 29 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 12 2017

 

 


Daily Technical Chart for (OTC: CRYO)

Daily Technical Chart for (OTC: CRYO)


Stay tuned for daily updates and more on (OTC: CRYO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CRYO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CRYO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CRYO and does not buy, sell, or trade any shares of CRYO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/